Evolution of fit-for-purpose biomarker validations: an LBA perspective

Area of Science:

• Biochemistry
• Pharmacology
• Clinical Diagnostics

Background:

• Biomarker ligand-binding assays are essential tools in drug development.
• Current regulatory guidance for validating these assays is fragmented.
• Scientists often need to synthesize validation strategies from multiple sources.

Purpose of the Study:

• To summarize key considerations for validating biomarker assays.
• To provide a framework for applying validation strategies in drug development.
• To address the lack of a single, comprehensive validation guideline.

Main Methods:

• Literature review of existing validation approaches.
• Synthesis of best practices for assay validation.
• Development of a practical framework for scientists.

Main Results:

• Identification of critical parameters for biomarker assay validation.
• A structured approach to designing validation studies.
• Guidance on adapting validation for different assay types and uses.

Conclusions:

• A unified approach to biomarker assay validation is needed.
• This summary offers a practical guide for scientists.
• Effective validation supports reliable clinical study results in drug development.